Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Medication By Investing.com
This collaboration gives an built-in resolution for purchasers searching for to outsource…
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC improvement By Investing.com
Samsung (KS:) Biologics to supply ADC providers at new devoted facilityProlonged collaboration…
ADMA Biologics Proclaims Partial Paydown of Senior Time period Mortgage Credit score Facility By Investing.com
Money on Hand Utilized to Repay $30 Million of Senior Secured Time…
HCW Biologics Pronounces Pricing of $6.9 Million Registered Direct Providing and Concurrent Non-public Placement Priced Above Market Below NASDAQ Guidelines By Investing.com
MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (HCWB…
WuXi Biologics Germany to Improve Capabilities with New Prefilled Syringes Line By Investing.com
LEVERKUSEN, Germany, Nov. 13, 2024 /PRNewswire/ -- WuXi Biologics (HK:) ("WuXi Bio")…
LakeShore Biopharma Initiates Biologics License Utility of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan By Investing.com
GAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd…
GenSight Biologics Stories Interim Monetary Outcomes for the First Half of 2024, Gives Business Updates By Investing.com
Optimized money administration, renegotiation of monetary obligations and ongoing monetary self-discipline end…
Almirall’s H1 2024 Outcomes: Almirall Delivers Robust Efficiency within the First Half of 2024, Reaching Web Gross sales Progress of 6.7% Pushed by Its European Dermatology Business and Accelerating Biologics By Investing.com
Robust progress trajectory maintained with Web Gross sales improve of 6.7% to…
